Irish-headquartered medtech giant working through spin out of diabetes business and focus on smaller, targeted acquisitions

Irish-headquartered medtech giant working through spin out of diabetes business and focus on smaller, targeted acquisitions

Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardiovascular and diabetes tech.